Both adjuvant and maintenance therapies are needed in women with symptomatic adenomyosis after uterus-sparing treatment
Other
OA: diamond
CC0
⤵ 2 in-corpus citations
AI-generated summary
This study investigated the necessity of both adjuvant and maintenance therapies for women experiencing symptomatic adenomyosis after uterus-sparing surgical treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (24)
- Comparison of recurrence rate and risk factors in patients with focal adenomyosis with and without medical treatment after conservative surgery via openalex
- Comparison of the treatment efficacies of HIFU, HIFU combined with GnRH-a, and HIFU combined with GnRH-a and LNG-IUS for adenomyosis: A systematic review and meta-analysis via openalex
- Conservative surgical treatment of adenomyosis to improve fertility: Controversial values, indications, complications, and pregnancy outcomes via openalex
- In Search of an Imaging Classification of Adenomyosis: A Role for Elastography? via openalex
- Letter to the editor: Adjuvant or maintenance therapy may be needed in adenomyosis patients after uterus-sparing surgery via openalex
- Maintenance dienogest therapy following adjuvant gonadotropin-releasing hormone agonist treatment after uterus-sparing surgery in adenomyosis: A retrospective cohort study via openalex
- Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study via openalex
- Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma via openalex
- Risk of Recurrence and Reintervention After Uterine-Sparing Interventions for Symptomatic Adenomyosis via openalex
- Treatment of infertile women with adenomyosis with a conservative microsurgical technique and a gonadotropin-releasing hormone agonist via openalex
- W4323045929 via openalex
- W4360620468 via openalex
- W6811030357 via openalex
- W6845834062 via openalex
- W6847074453 via openalex
- W2033363713 via openalex
- W2042734806 via openalex
- W2065386825 via openalex
- W2516163322 via openalex
- W2990536359 via openalex
- W2997191010 via openalex
- W4280627612 via openalex
- W4309541611 via openalex
- W4313546221 via openalex
Cited by (3)
- Development and validation of a nomogram to predict symptomatic recurrence following laparoscopic adenomyomectomy 2026
- High-intensity focused ultrasound combined with hysteroscopic insertion of levonorgestrel-releasing intrauterine system for intrinsic adenomyosis: a retrospective observational study 2025
- High-intensity focused ultrasound (HIFU) along may not be a good choice for treatment of adenomyosis 2023
Source provenance
- europepmc
- last seen: 2026-10-11T09:27:45.537177+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-11T06:13:24.112650+00:00
License: CC0
· commercial use OK